Share This Page
Drug Price Trends for NDC 76282-0757
✉ Email this page to a colleague
Average Pharmacy Cost for 76282-0757
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DOFETILIDE 500 MCG CAPSULE | 76282-0757-60 | 0.19624 | EACH | 2025-11-19 |
| DOFETILIDE 500 MCG CAPSULE | 76282-0757-60 | 0.20871 | EACH | 2025-10-22 |
| DOFETILIDE 500 MCG CAPSULE | 76282-0757-60 | 0.20848 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 76282-0757
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 76282-0757
Introduction
The drug with the National Drug Code (NDC) 76282-0757 is a critical pharmaceutical product within its therapeutic niche. Given the increasing complexity of drug markets, understanding the current positioning, competitive landscape, and future pricing trajectories of NDC 76282-0757 is essential for stakeholders including manufacturers, investors, healthcare providers, and policymakers. This report synthesizes market dynamics, formulates price projections, and offers strategic insights into this drug’s trajectory.
Product Overview and Therapeutic Market Context
The NDC 76282-0757 identifies a specific formulation of a branded or generic medication. Based on publicly available databases and FDA records, this NDC corresponds to [insert specific drug name], a [drug class] indicated for [primary therapeutic use].
Market size and prevalence indicate a growing demand driven by [reasons such as disease prevalence, aging population, or unmet needs]. The drug's efficacy, safety profile, and regulatory approval status shape its current market share.
Current Market Landscape
Market Positioning
NDC 76282-0757's market presence is influenced by:
- Regulatory Status: Approved by the FDA in [year], with recent supplemental approvals expanding indications.
- Market Penetration: Factoring in model adoption rates within hospitals, clinics, and retail pharmacies.
- Competitive Alternatives: Other branded or generic drugs targeting the same indications, such as [list competitors]. A notably competitive environment can suppress prices and limit margins.
Market Drivers
- Clinical Necessity: The drug treats [specific condition/conditions], which exhibit rising prevalence.
- Advancements in Formulation: Introduction of [e.g., sustained-release, combination therapies] enhances patient compliance and treatment outcomes.
- Regulatory incentives: Patent protections, exclusivity periods, and biologic regulations influence market exclusivity.
Market Challenges
- Price Sensitivity: Payer pressure and high copays impact revenue.
- Generic Competition: The entry of generics post-patent expiry influences pricing strategies.
- Pricing Transparency: Increased transparency and value-based pricing models exert pressure.
Historical Price Trends
Analyzing pricing data from sources like IQVIA, Red Book, and Medicaid drug price files, reveals the following:
- Average Wholesale Price (AWP): Initially set at $___ per unit upon launch, with fluctuations reflecting market dynamics.
- Reimbursement Trends: Medicaid and Medicare rates, along with private insurer negotiations, modulate net prices.
- Discounting and Rebates: Industry-standard rebates, negotiated discounts, and pharmacy benefit manager (PBM) discounts significantly influence actual transaction prices.
Forecasting Price Trajectories
Projected price trends for NDC 76282-0757 over the next five years consider multiple variables:
1. Patent and Exclusivity Status
- If patent exclusivity is nearing expiration ([expected date]), generic competition is likely to enter, precipitating price erosion.
2. Competition Dynamics
- Pre-Patent Expiry: The drug will retain premium pricing, especially if it maintains differentiation.
- Post-Patent Expiry: Anticipate a [percentage]% decrease in prices, aligning with historical generic entry patterns.
3. Market Penetration and Volume Growth
- Effective uptake strategies and increased indications could bolster sales volume, potentially offsetting price declines.
4. Healthcare Policy and Reimbursement Trends
- Shift towards value-based care will likely pressure prices downward, encouraging manufacturers to justify pricing through improved outcomes.
5. Development of Biosimilars and Generics
- Entry of biosimilars or generics will typically reduce prices by 30% to 50% within the first two years post-approval.
Price Projection Model
| Year | Estimated Average Price per Unit | Key Assumptions |
|---|---|---|
| 2023 | $____ | Current market prices; no new competition |
| 2024 | $____ | Patent protection; increased demand for targeting indications |
| 2025 | $____ | Approaching patent expiry; early generic market entry anticipated |
| 2026 | $____ | Intensified generic competition; market saturation |
| 2027+ | $____ | Stabilization at lower price points post-generic entry |
(Note: Actual figures depend on further real-world data not publicly available here; these are illustrative estimates.)
Strategic Implications for Stakeholders
- Manufacturers should capitalize on patent protections and invest in value-added formulation enhancements to sustain premium pricing.
- Investors should monitor patent expirations and biosimilar development pipelines for market entry risks.
- Healthcare providers and payers should advocate for value-based reimbursement models aligning costs with outcomes.
- Regulatory agencies may influence price trajectories through patent law reforms or pricing transparency initiatives.
Regulatory and Patent Landscape
Understanding the patent lifecycle and regulatory environment provides essential context:
- The drug's patent status, therapeutic indications, and orphan drug protections (if any) influence market exclusivity.
- Pending patent challenges or recent regulatory amendments could accelerate price declines or market entry of generics.
Conclusion
NDC 76282-0757 occupies a significant role within its therapeutic segment, with a market influenced by patent protections, emerging biosimilar options, and evolving reimbursement policies. Price projections indicate a gradual decline expected following patent expiry, with potential stabilization based on the degree of market competition and regulatory shifts. Strategic positioning now can optimize revenue streams while mitigating competitive risks.
Key Takeaways
- Patent status and timing are critical determinants of near- and mid-term pricing.
- Generic and biosimilar entries are anticipated to substantially reduce prices within 2-3 years post-patent expiry.
- Market demand drivers—such as increasing disease prevalence and expanded indications—can offset some pricing pressures through volume growth.
- Healthcare policy trends favor value-based pricing and transparency, which may exert downward pressure on drug prices.
- Long-term success hinges on innovation, clinical differentiation, and strategic management of patent and regulatory landscapes.
FAQs
1. How does patent expiration influence the pricing of NDC 76282-0757?
Patent expiration typically allows generic or biosimilar competitors to enter the market, creating price competition that can reduce the drug’s price by up to 50% or more, depending on market conditions.
2. What factors could accelerate or slow down the price decline of this drug?
Factors such as regulatory delays in biosimilar approval, patent litigation outcomes, market demand elasticity, and payer policies influence the speed of price reductions.
3. How can manufacturers sustain profitability post-patent expiration?
By investing in new formulations, expanding indications, improving clinical outcomes, and engaging in exclusive supply agreements, manufacturers can maintain competitive advantage.
4. What role do reimbursement policies play in the future pricing of this drug?
Reimbursement models emphasizing value-based care can compress margins, incentivizing providers and payers to negotiate lower prices aligned with clinical efficacy.
5. How does the competitive landscape impact long-term market share for NDC 76282-0757?
A competitive environment with effective branding and differentiated clinical benefits can preserve market share despite pricing pressures, whereas commoditization post-generic entry can diminish revenues.
Sources
- FDA NDC Directory — [link]
- IQVIA Market Intelligence Reports — [link]
- Red Book Data for Wholesale Prices — [link]
- Medicaid Drug Pricing Files — [link]
- Industry Analysis and Patent Status Reports — [link]
Note: Specific current price data, patent expiry dates, and competitive developments should be confirmed through ongoing industry monitoring for precise decision-making.
More… ↓
